Checkmate017_1 | R Documentation |
Kaplan-Meier digitized data from Checkmate017, figure 1 (PMID 26028407). A reported sample size of 272 for a primary endpoint of OS in lung cancer.
Checkmate017_1
A data frame of 272 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (d1, nivolumab) | |
Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med 2015; 373: 123–35.
summary(Checkmate017_1)
kmplot(Checkmate017_1)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.